- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02254356
Zilver Flex Post-Market Study in Japan
March 29, 2018 updated by: Cook Group Incorporated
Zilver PTX Post-Market Surveillance Study of Bare Metal Stents for Treating Femoropopliteal Artery Disease in Japan
Japanese post market clinical study of the Zilver Flex device.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
239
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Fukuoka, Japan, 814-0001
- Fukuoka Sanno Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Symptomatic peripheral arterial disease (PAD) involving the above-the-knee femoropopliteal arteries
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Zilver
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Occurrence of stent fracture
Time Frame: 3 years
|
3 years
|
Rate of adverse events
Time Frame: 3 years
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael D Dake, MD, Department of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, CA
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2012
Primary Completion (Actual)
December 26, 2017
Study Completion (Actual)
December 26, 2017
Study Registration Dates
First Submitted
September 29, 2014
First Submitted That Met QC Criteria
September 29, 2014
First Posted (Estimate)
October 1, 2014
Study Record Updates
Last Update Posted (Actual)
March 30, 2018
Last Update Submitted That Met QC Criteria
March 29, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-005-FLX
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Arterial Disease (PAD)
-
Spectranetics CorporationRecruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | PAD | PAD - Peripheral Arterial Disease | Dissection | Arterial DissectionUnited States
-
Alucent BiomedicalActive, not recruitingPAD - Peripheral Arterial DiseaseAustralia
-
Alucent BiomedicalActive, not recruitingPAD - Peripheral Arterial DiseaseAustralia
-
Vibrato Medical, Inc.Active, not recruitingPeripheral Arterial Disease (PAD)United States
-
Cook Group IncorporatedCompletedPeripheral Arterial Disease (PAD)
-
Gardia MedicalCompletedPeripheral Arterial Disease (PAD)United States, Germany
-
SanofiCompletedPeripheral Arterial Disease (PAD)Japan
-
Cook Group IncorporatedCompletedPeripheral Arterial Disease (PAD)
-
Hoffmann-La RocheCompletedPeripheral Arterial Disease (PAD)United States, Canada, Australia
-
Cook Group IncorporatedCompleted
Clinical Trials on Zilver Flex Bare Metal Stent
-
Skane University HospitalCompletedVascular Diseases
-
North Texas Veterans Healthcare SystemTerminatedPeripheral Vascular Diseases | Chronic Total Occlusion of Artery of the ExtremitiesUnited States
-
Centro de estudios en Cardiologia IntervencionistaEucatech AGCompletedCoronary Artery DiseaseArgentina
-
University of SaskatchewanUnknown
-
Cook Group IncorporatedCompleted
-
Biotronik AGCompletedDe Novo and Re-stenosed Coronary Artery LesionsSwitzerland, Netherlands, Israel, Spain, Latvia, Germany, Austria, Belgium, France, Ireland
-
Catholic University of the Sacred HeartCompletedSaphenous Vein Graft Disease
-
Chinese Society of Interventional RadiologyCompletedVertebral Artery Origin StenosisChina
-
Boston Scientific CorporationCompletedSymptomatic Ischemic Saphenous Vein Graft DiseaseUnited States, Canada
-
A.O. Ospedale Papa Giovanni XXIIIMedtronic; Case Western Reserve UniversityCompletedAcute Myocardial InfarctionItaly